Our current research exhibits the regulation of Gab2 on adipose tissue inflammation and brown adipose tissue function, which expands and emphasizes the therapeutic role of Gab2 and provides a novel target for the treatment of obesity and associated complications. Here, GAB2 is linked to obesity due to melanocortin 4 receptor deficiency.